How much does Mounjaro cost – and does health insurance pay?

In Germany, Mounjaro (active ingredient tirzepatide) comes as a KwikPen with four weekly doses. So one pen covers roughly a month. The price rises with the strength. Prescription-only medicines in Germany have a uniform pharmacy retail price, so prices hardly differ between pharmacies.

As of September 2026, rounded German pharmacy prices according to a price comparison site. Prices may change – if in doubt, ask your pharmacy.

For context: Lilly changed its list prices in Germany in February 2025. The 2.5 mg starting dose became cheaper, the higher strengths considerably more expensive. On the 15 mg maintenance dose, this adds up to well over €6,000 per year (13 pens). Which dose you need depends on how you respond – more on this in Mounjaro dosage.

Statutory health insurance (GKV), goal weight loss: No. § 34 SGB V excludes medicines whose main purpose is improving quality of life – explicitly including drugs for slimming, appetite suppression or regulating body weight. This applies even if you have severe obesity with comorbidities.

GKV, type 2 diabetes: If Mounjaro is prescribed to treat type 2 diabetes that is not adequately controlled, you get a statutory prescription. You then only pay the usual co-payment of at most €10 per pack. For diabetes use, Lilly agreed a confidential reimbursement price with the German health insurers in 2025.

Are there changes in 2026? Not yet. The Bundestag’s Petitions Committee has forwarded a petition on cost coverage to the Federal Ministry of Health, because new scientific findings justify a review. In 2026, the chair of the G-BA (Federal Joint Committee) signalled that reimbursement for clearly defined patient groups would be conceivable – but only if lawmakers change the law. As of September 2026, no such change in the law has been made.

Private health insurance (PKV): Here it depends on your plan and medical necessity. Typical requirements are a BMI of 30 or more (or 27 or more with comorbidities such as high blood pressure or prediabetes), a doctor’s justification and documented unsuccessful attempts with diet and exercise. Ideally, clarify reimbursement in writing before starting treatment. If you are turned down, you can appeal.

Beihilfe (civil servants’ allowance): Many Beihilfe and subsidy offices follow the lifestyle exclusion. The health scheme for federal railway civil servants (KVB), for example, does not subsidise drugs “for slimming, appetite suppression or regulating body weight”, but it does cover Mounjaro for type 2 diabetes. The federal government and the states have their own rules – ask your Beihilfe office.

This is a general overview of the situation in Germany, not legal or insurance advice.

• Statutory prescription (pink): only for type 2 diabetes. The insurer pays, you pay the co-payment.
• Private prescription (blue or white): when used for weight loss. You pay the full pharmacy price yourself – even if you have statutory insurance.
• E-prescription: Both types also exist in digital form. You can redeem them at any pharmacy, including licensed online pharmacies.

Tip: Keep your pharmacy receipts – you will need them if you submit a claim to PKV or Beihilfe.

Mounjaro is prescription-only. According to the prescribing information (SmPC), it is approved for weight management in adults with a BMI of 30 or more, or a BMI of 27 or more plus at least one weight-related comorbidity – always in addition to fewer calories and more exercise.

1. GP practice: The first port of call for most people. Blood pressure, blood sugar (HbA1c), kidney values and pre-existing conditions are checked there.
2. Diabetology or obesity clinic: Makes sense if you have diabetes, severe obesity or several comorbidities.
3. Telemedicine: Online doctors’ practices also issue private prescriptions. In 2026, the German consumer advice centres (Verbraucherzentralen) criticised that some platforms check neither identity nor weight. An offer is only trustworthy if real information is requested and a doctor takes responsibility.

• Bring current values: weight, height, waist circumference, blood pressure and – if available – lab results.
• Mention all medications, including blood pressure drugs, the pill and supplements. See interactions.
• Explain what you have tried so far (diet, exercise, programmes). This often matters for PKV and Beihilfe.
• Ask specifically: What is the target dose, how often will we check in, and what happens when stopping?
• Talk openly about the cost. A plan for the maintenance dose helps you estimate the expenses realistically.

In Germany, Wegovy (semaglutide) costs about €170 to €280 per pen depending on strength, which also contains four weekly doses (as of September 2026). On the maintenance dose, Wegovy is therefore usually cheaper than high-dose Mounjaro. Which medication suits you better does not depend on price alone, though – see Mounjaro vs. Wegovy.

Because of the high cost, some people switch to unregulated “research” tirzepatide powders that are sold as research chemicals “not for human use”.

If the price is the problem, it is better to talk openly with your doctor about it – for example about whether a lower maintenance dose might be enough for you.